Company profile
Latest filings (excl ownership)
Latest ownership filings
No filings
News
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
23 Apr 24
MorphoSys AG Form SC TO-T/Amended Shows Novartis BidCo AG Bought 2,023,370 Shares Of Common Stock Or About A 5.36% Stake; Highest Price Paid Was €67.95 Per Share
15 Apr 24
MorphoSys' Management Board And Supervisory Board Recommend Shareholders Accept Public Takeover Offer By Novartis For €68.00 Per Share In Cash
11 Apr 24
Novartis Tender Offer For Morphosys Commences @€68.00/Share
11 Apr 24
MorphoSys Bags US Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
22 Mar 24
Press releases
MorphoSys' Management Board and Supervisory Board Recommend Shareholders Accept Public Takeover Offer by Novartis
11 Apr 24
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
22 Mar 24
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
13 Mar 24
Invitation to MorphoSys' Full Year Results 2023 Conference Call on March 14, 2024
7 Mar 24